RESMED INC — Director's Dealing 2013

May 22, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-05-20

Reporting Person: QUINN MICHAEL A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-20	ResMed Common Stock	M	48000	$12.738	Acquired	344000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-20	ResMed Common Stock Options	$12.738	M	48000	Disposed	2014-07-02	ResMed Common Stock (48000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Chess Depositary Instruments	400000	Direct
ResMed Chess Depositary Instruments	306000	Indirect

Footnotes

F1: Represents date options first became available. Options vest 1/3 each year on the anniversary of the grant.

F2: These shares are held as CDIs on the Australian Securities Exchange which represents 40,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.

F3: These shares are held as CDIs on the Australian Securities Exchange which represents 30,600 NYSE shares. 1 NYSE share is equal to 10 CDIs.